Tagged with pharma

SaxoTV

Neighbour: Shorting GSK as pharma stocks catch...

595 views September 10, 2015

Joe Neighbour has been tracking GlaxoSmithKline, a big pharma stock that seems to be in a...

SaxoTV

Knuthsen: As Novo beats, why Danish stocks are...

611 views August 05, 2015

The Danish large cap OMX Copenhagen 20 index has risen more than 40% this year outperforming most...

SaxoTV

Earnings Season: GSK will disappoint but pharma...

382 views May 05, 2015

Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...

SaxoTV

Are high returns from marijuana companies just...

523 views August 01, 2014

This week the New York Times, in an editorial, urged US lawmakers to legalise marijuana. Some...

SaxoTV

Berger: Biogen's healthy recovery

152 views July 24, 2014

Serge Berger suggests buying Biogen, a biotech firm which has reported sales of its Multiple...

SaxoTV

Just what is Monsanto up to?

1,321 views June 24, 2014

It’s been revealed that talks between US agricultural giant Monsanto and its rival Syngenta have...

SaxoTV

Should we all be investing in Irish healthcare?

490 views June 18, 2014

What is it with Ireland's healthcare companies? In the past week alone, we've heard that the US...

SaxoTV

Garnry: "Astra Zeneca shareholders blew it"

278 views May 19, 2014

AstraZeneca’s stock price tumbled 14 percent on Monday morning after the company rejected...

SaxoTV

Astra Zeneca and Pfizer: Five things you need...

192 views May 13, 2014

As the Astra Zeneca Pfizer deal gets more bad tempered and political, what are the side effects...

SaxoTV

Buying the biotech boost

209 views May 06, 2014

Leading Bio tech firms, have seen around thirty percent growth in the last year and prospects...

SaxoTV

Pfizer-AstraZeneca: 'Deal will likely get done'

182 views April 29, 2014

What next in the drama surrounding the proposed merger of pharmaceutical giants Pfizer and...

SaxoTV

AstraZeneca finds Pfizer bid a bitter pill to...

129 views April 28, 2014

The boss of British pharmaceutical giant AstraZeneca, Pascal Soriot, has been emphasising the...